Physician profile
Aena D Han
NPI 1679612212
$796.34
in general payments reported to CMS, 2019-2025
12 companies · $268 in 2025
The $268 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.16 · 2020: $54.99 · 2022: $108 · 2023: $152 · 2024: $195 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $176.34 | 2020-2025 | Doc Band |
| Sanofi Pasteur INC. | $120.21 | 2022-2024 | |
| Glaxosmithkline, LLC. | $105.80 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Merck Sharp & Dohme LLC | $100.51 | 2020-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Novo Nordisk INC | $71.63 | 2023-2025 | Wegovy, Saxenda |
| Biomarin Pharmaceutical INC. | $60.87 | 2024 | Voxzogo 1.2mg |
| Hologic Sales and Service, LLC | $37.83 | 2025 | Aptima, Thinprep 2000 Processor |
| Phadia US INC. | $36.12 | 2024-2025 | Immunocap |
| Oxford Immunotec USA INC | $24.11 | 2022 | |
| Aimmune Therapeutics, INC. | $21.74 | 2025 | Vowst |
| Dexcom, INC. | $21.31 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $19.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aena Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.